Kevin will lead brand development, marketing and pricing strategy as a core part of the commercialisation process for...
Kevin will lead brand development, marketing and pricing strategy as a core part of the commercialisation process for...
Dr Kolli brings extensive NHS and pharmaceutical industry experience to LEO Pharma, gained from a career in both the...
Ian is currently non-executive chairman of Multiplicom NV, focused on the development and commercialization of DNA...
Paul joins Internis from Sandoz, where he was Head of Biopharmaceuticals. Paul began his career with Galen 16 years...
Kunz brings exceptional worldwide leadership experience to DIA as former president of the Global Health and Life...
Carsten Hellmann joins Sanofi from Chr. Hansen Holding A/S and will take the position of Executive Vice President...
Steve will serve as a Board Member up to and including the ABPI’s annual general meeting in 2014.
Anna will be leaving her current role asManaging Director of Packer Forbes Communications on July 31.
As Group Chief Operating Officer, Gowland will further enhance operational performance of all API and Formulated...
They are: Professor Finbarr Martin, Consultant Physician in General and Geriatric Medicine at Guy's and St Thomas' NHS...
Patti joins Tissue Regenix from Polyremedy where she was Director of US Sales.
Gil Yosipovitch is the newly announced Chair of the Department of Dermatology and Director of the Temple Itch Center...
Dr Love was most recently the Executive Vice-President of Research and Development at Onyx Pharmaceuticals, overseeing...
They are: Dame Valerie Beral, Director of the Cancer Epidemiology Unit at the University of Oxford; Professor...
His role at Ziarco will be to provide input on the company's corporate, R&D strategy and business plans.